GuidelineAnnals of the rheumatic diseases2021

EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors.

Marie Kostine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.